Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Farmers Insurance
US Department of Justice
Baxter
US Army
Fuji
Covington
Dow
Colorcon
Chubb

Generated: October 24, 2017

DrugPatentWatch Database Preview

CLOBEX Drug Profile

« Back to Dashboard

Which patents cover Clobex, and what generic Clobex alternatives are available?

Clobex is a drug marketed by Galderma Labs Lp and Galderma Labs and is included in three NDAs. There are seven patents protecting this drug and three Paragraph IV challenges.

This drug has fifty-nine patent family members in twenty-four countries.

The generic ingredient in CLOBEX is clobetasol propionate. There are thirteen drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the clobetasol propionate profile page.

Summary for Tradename: CLOBEX

US Patents:7
Applicants:2
NDAs:3
Suppliers / Packagers: see list5
Bulk Api Vendors: see list40
Clinical Trials: see list13
Patent Applications: see list4,335
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CLOBEX at DailyMed

Pharmacology for Tradename: CLOBEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Galderma Labs Lp
CLOBEX
clobetasol propionate
LOTION;TOPICAL021535-001Jul 24, 2003ABRXYesYes► Subscribe► Subscribe ► Subscribe
Galderma Labs
CLOBEX
clobetasol propionate
SHAMPOO;TOPICAL021644-001Feb 5, 2004ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Galderma Labs
CLOBEX
clobetasol propionate
SHAMPOO;TOPICAL021644-001Feb 5, 2004ABRXYesYes► Subscribe► Subscribe ► Subscribe
Galderma Labs Lp
CLOBEX
clobetasol propionate
SPRAY;TOPICAL021835-001Oct 27, 2005ATRXYesYes► Subscribe► SubscribeY ► Subscribe
Galderma Labs Lp
CLOBEX
clobetasol propionate
SPRAY;TOPICAL021835-001Oct 27, 2005ATRXYesYes► Subscribe► SubscribeY ► Subscribe
Galderma Labs
CLOBEX
clobetasol propionate
SHAMPOO;TOPICAL021644-001Feb 5, 2004ABRXYesYes► Subscribe► SubscribeY ► Subscribe
Galderma Labs
CLOBEX
clobetasol propionate
SHAMPOO;TOPICAL021644-001Feb 5, 2004ABRXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: CLOBEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Galderma Labs Lp
CLOBEX
clobetasol propionate
LOTION;TOPICAL021535-001Jul 24, 2003► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for CLOBEX

Drugname Dosage Strength RLD Submissiondate
clobetasol propionateSpray0.05%Clobex9/29/2008
clobetasol propionateTopical Shampoo0.05%Clobex1/9/2008
clobetasol propionateLotion0.05%Clobex3/27/2006

Non-Orange Book Patents for Tradename: CLOBEX

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,886,038 Composition and method for treatment of psoriasis► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: CLOBEX

Country Document Number Estimated Expiration
Hungary0102190► Subscribe
Germany122006000024► Subscribe
Brazil9911849► Subscribe
Austria444054► Subscribe
Germany69722546► Subscribe
Japan4091257► Subscribe
Russian Federation2001101891► Subscribe
JapanH10101549► Subscribe
China1171579► Subscribe
South Africa200006073► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Cipla
US Army
Mallinckrodt
Daiichi Sankyo
McKesson
Novartis
Chinese Patent Office
Merck
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot